Microsoft is pledging $20 million to support COVID-19 data and research initiatives from institutions including University of Washington School of Medicine and the Washington State Department of ...
A large-scale genomic investigation has identified new genetic risk factors for idiopathic pulmonary fibrosis (IPF) and revealed substantial overlap with pathways that also predispose individuals to ...
Introduction The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded ...
HHS, VA and energy department partner to use supercomputer, AI for COVID-19 data analysis: 4 details
HHS partnered with the VA and Department of Energy to coordinate and share COVID-19 health data. 1. The initiative, dubbed COVID-19 Insights Partnership, formalizes the framework for the VA and HHS to ...
The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana ...
Data from around the world support the general safety of the COVID-19 vaccines. Some people online, however, incorrectly claim that illegally obtained data from New Zealand show the vaccines have ...
COVID-19 severity can be predicted by a model with 5 variables: respiratory rate, systolic blood pressure, plasma albumin, LDH, and CRP.
Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...
VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback